Interactions between certain HIV and cholesterol-lowering statin drugs can increase the risk of musc

The U.S. Food and Drug Administration (FDA) on March 1 issued its updated recommendations concerning drug-drug interactions between drugs for human immunodeficiency virus (HIV) known as protease inhibitors and certain cholesterol-lowering drugs known as statins.

Protease inhibitors and statins taken together may raise the blood levels of statins and increase the risk for muscle injury (myopa...